SMS PHARMACEUTICAL chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 75.01
Dividend & Yield0.30₹ (0.35%)
Beta 1.44
Market capitalization 7.03B
Operating cash flow N/A
ESG Scores unknown

Company description

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Sector: Healthcare - Industry: Drug Manufacturers—General

Financial Ratios
Quick Ratio0.88
Working Capital0.54
Return On Equity0.15
Debt To Equity0.36
Fixed Asset Ratio0
Fixed Interest Cover9.89

Financial data

Financial Statements

Cashflow Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Change To Liabilities -280.5M 89.83M -37.58M 209.46M
Total Cashflows From Investing Activities -165.77M -346.73M -425.64M -1.52B
Net Borrowings -30.21M -24.64M 84.6M 981.62M
Total Cash From Financing Activities -148.92M -129.17M -24.02M 920.18M
Change To Operating Activities -23.19M -35.72M -87.64M 321.37M
Issuance Of Stock
Net Income 317.5M 400.48M 315.74M 625.27M
Change In Cash 3.46M 21.67M -52.53M 308.79M
Effect Of Exchange Rate
Total Cash From Operating Activities 318.15M 497.57M 397.12M 904.53M
Depreciation 197.6M 191.67M 219.57M 221.89M
Change To Account Receivables -28.63M -19.76M -227.48M -569.88M
Other Cashflows From Financing Activities -98.33M -83.37M -66.29M -61.44M
Change To Netincome 286.25M 163.56M 136.06M 179.61M
Capital Expenditures -85.53M -348.38M -427.34M -1.52B

Income Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Research Development
Income Before Tax 516.44M 609.49M 496.41M 926.82M
Net Income 317.5M 400.48M 315.74M 625.27M
Selling General Administrative 342.6M 372.49M 410.15M 414.94M
Gross Profit 1.39B 1.39B 1.34B 1.85B
Ebit 747.61M 729.54M 609.75M 1.01B
Operating Income 747.61M 729.54M 609.75M 1.01B
Interest Expense -147.7M -114.2M -111.93M -102.54M
Income Tax Expense 198.94M 209.01M 180.67M 301.55M
Total Revenue 4.64B 4.67B 4.14B 5.65B
Cost Of Revenue 3.25B 3.28B 2.8B 3.8B
Total Other Income ExpenseNet -231.17M -120.05M -113.34M -87.49M
Net Income From Continuing Ops 317.5M 400.48M 315.74M 625.27M
Net Income Applicable To Common Shares 317.5M 400.48M 315.74M 625.27M

Balance Sheet Statement 2018-03-31 2019-03-31 2020-03-31 2021-03-31
Total Liabilities 2.18B 2.37B 2.6B 4.02B
Total Stockholder Equity 2.84B 3.22B 3.48B 4.11B
Other Current Liabilities 53.23M 108.15M 141.37M 216.16M
Total Assets 5.03B 5.59B 6.08B 8.12B
Common Stock 84.65M 84.65M 84.65M 84.65M
Other Current Assets 21.4M 36.41M 103.11M 62.54M
Retained Earnings 2.05B 2.42B 2.68B 3.31B
Treasury Stock 15.5M 15.5M 15.5M 15.5M
Cash 126.31M 147.98M 95.44M 404.23M
Total Current Liabilities 1.21B 1.43B 1.45B 1.94B
Other Stockholder Equity 15.5M 15.5M 15.5M 15.5M
Property, Plant, and Equipment 2.87B 2.98B 3.22B 4.63B
Total Current Assets 1.68B 2.08B 2.19B 3.09B
Net Tangible Assets 2.84B 3.21B 3.47B 4.09B
Net Receivables 455.94M 517.06M 678.57M 1.23B
Accounts Payable 326.92M 421.74M 395.51M 549.54M


Insider Transactions

Here are the insider transactions of stock shares related to SMS PHARMACEUTICAL:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Potluri Infra Projects Pvt. Ltd.I2020-12-31Promoter
Murthy (T V V S N)Other at price 1.58 per share.D2020-12-31Executive Vice Chairman661.18k
Potluri Infra Projects Pvt. Ltd.D2020-12-21Promoter661.18k
Murthy (T V V S N)D2020-12-21UNREPORTED661.18k
Potluri (Krishna Chaitanya)Sale at price 1.47 per share.D2020-12-17UNREPORTED11.3k
Murthy (T V V S N)Other at price 12.86 per share.D2020-12-08Executive Vice Chairman74.84k
Potluri Infra Projects Pvt. Ltd.Other at price 1.29 per share.D2020-12-08Promoter581.14k
Potluri (Hima Bindu)I2020-12-08Promoter
Potluri Infra Projects Pvt. Ltd.I2020-12-08Promoter
Talluri (Annapurna)Other at price 1.29 per share.D2020-12-08Promoter3.37M
Talluri (Annapurna)Other at price 1.29 per share.D2020-12-08Promoter3.37M
Murthy (T V V S N)I2020-12-08Executive Vice Chairman
Potluri (Hima Bindu)Other at price 1.28 per share.D2020-12-08Promoter1.39M
Potluri (Ramesh Babu)Other at price 1.28 per share.D2020-12-08Director1.47M
Potluri (Ramesh Babu)I2020-12-08Director
Potluri (Vamsi Krishna)I2020-12-07Promoter
Potluri (Vamsi Krishna)Other at price 1.29 per share.D2020-12-07Promoter5.32M
Murthy (T V V S N) HUFOther at price 1.32 per share.D2020-12-07Promoter586.34k
Murthy (T V V S N) HUFOther at price 1.32 per share.D2020-12-07Promoter586.34k
Gopineedi (Sudeepthi)Sale at price 1.14 per share.D2020-11-25Promoter405k
Murthy (T V V S N)Sale at price 1.12 per share.D2020-11-25Executive Vice Chairman4.88M
Potluri (Vamsi Krishna)Acquisition at price 1.12 per share.D2020-11-25Promoter3.2M
Potluri Laboratories Pvt. Ltd.Acquisition at price 1.14 per share.D2020-11-25Institution- Corporation465.9k
Potluri Infra Projects Pvt. Ltd.Acquisition at price 1.14 per share.D2020-11-25Promoter134.1k
Potluri Laboratories Pvt. Ltd.Acquisition at price 1.25 per share.D2020-08-17Institution- Corporation422k
Potluri (Ramesh Babu)Sale at price 1.25 per share.D2020-08-17Director422k
Murthy (T V V S N)D2020-03-06Executive Vice Chairman2.76M
Talluri (Annapurna)D2020-03-06Promoter1.02M
Potluri (Hima Bindu)D2020-03-06Promoter1.02M
Potluri (Vamsi Krishna)D2020-03-06Promoter2.76M
Potluri (Vamsi Krishna)D2019-09-11Promoter20k
Koneru (Sukumari)D2019-09-11UNREPORTED20k
Potluri Laboratories Pvt. Ltd.D2017-06-19Promoter231.68k
Potluri Infra Projects Pvt. Ltd.D2017-06-19Promoter110k
Potluri (Ramesh Babu)D2016-09-30Executive Chairman3.15M
Potluru (Seeta Rama Bhahmam)D2016-02-12UNREPORTED6.45k
Potluru (Seeta Rama Bhahmam)D2016-02-05UNREPORTED25.15k
Potluri Laboratories Pvt. Ltd.D2015-12-02Promoter93k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SMS PHARMACEUTICAL. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SMS PHARMACEUTICAL

Here is the result of two systematic investment strategies applied to SMS PHARMACEUTICAL. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SMS PHARMACEUTICAL

The following chart shows the equity curve of the two systematic investment strategies applied to SMS PHARMACEUTICAL:

SMS PHARMACEUTICAL automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 26.38% on the backtest period.

Performance at glance

Performance

26.38 %

Latent gain

692.1 ₹

Invested capital

2623.4 ₹

Annualized return

6.28 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SMS PHARMACEUTICAL

This is the result of two momentum investment strategies applied to SMS PHARMACEUTICAL. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SMS PHARMACEUTICAL

The following chart shows all the entries opened by the momentum investment system on SMS PHARMACEUTICAL:

SMS PHARMACEUTICAL momentum entries
  • The first momentum investment strategy would give 36.5% of return on SMS PHARMACEUTICAL. That represents 1236.4₹ of latent gain with 3387.85₹ of employed capital.
  • The second momentum investment strategy would give 46.29% of return on SMS PHARMACEUTICAL. That represents 1076.65₹ of latent gain with 2326.1₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

36.5 %

Latent gain

1236.4 ₹

Invested capital

3387.85 ₹

Annualized return

-18.55 %
Performance at glance (2Q Momentum)

Performance

46.29 %

Latent gain

1076.65 ₹

Invested capital

2326.1 ₹

Annualized return

12.44 %

Momentum equity curve on SMS PHARMACEUTICAL

The following chart shows the equity curve of the two momentum strategies applied to SMS PHARMACEUTICAL:

SMS PHARMACEUTICAL momentum equity

Note: the dividends potentially given by SMS PHARMACEUTICAL are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SMS PHARMACEUTICAL

The following chart shows the employed capital evolution of the two momentum strategies on SMS PHARMACEUTICAL since the beginning:

SMS PHARMACEUTICAL

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on SMS PHARMACEUTICAL

Buy the dip entry openings on SMS PHARMACEUTICAL

SMS PHARMACEUTICAL

The performance achieved by the robo-advisor on SMS PHARMACEUTICAL is -40.8%. That represents -481.1$ of latent gain with 1179.1₹ of employed capital. The following chart shows SMS PHARMACEUTICAL stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SMS PHARMACEUTICAL, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-40.8 %

Latent gain

-481.1 ₹

Invested capital

1179.1 ₹

Annualized return

-18.55 %

Equity curve of the strategy applied to SMS PHARMACEUTICAL

The following chart shows the result of the investment strategy applied to SMS PHARMACEUTICAL:

SMS PHARMACEUTICAL

Note: the dividends potentially given by SMS PHARMACEUTICAL are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SMS PHARMACEUTICAL

The following chart shows the employed capital evolution since the beginning of the investment strategy on SMS PHARMACEUTICAL:

SMS PHARMACEUTICAL

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SMS PHARMACEUTICAL

In this section, I will compare the three previous investment strategies applied to SMS PHARMACEUTICAL.

Equity curve comparison on SMS PHARMACEUTICAL

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SMS PHARMACEUTICAL investment strategy comparison

Employed capital comparison on SMS PHARMACEUTICAL

SMS PHARMACEUTICAL investment comparison

Performance comparison on SMS PHARMACEUTICAL

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 26.38% 692.1₹ 2623.4₹ 6.28%
Momentum 1 quarter 36.5% 1236.4₹ 3387.85₹ 9.22%
Momentum 2 quarters 46.29% 1076.65₹ 2326.1₹ 12.44%
Non-directional -40.8% -481.1₹ 1179.1₹ -18.55%
Annualized return comparison

Automatic investment

6.28 %

Momentum 1Q

12.44 %

Momentum 2Q

12.44 %

Non-directional

-18.55 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SMS PHARMACEUTICAL:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between SMS PHARMACEUTICAL and the other stocks. There may be false positives or some missing correlated stocks. If the price of SMS PHARMACEUTICAL does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name SMS PHARMACEUTICAL
Country India
City Hyderabad
Address Plot No. 72
Phone 91 40 2525 9999
Website www.smspharma.com
FullTime employees 1080
Industry Drug Manufacturers—General
Sector Healthcare
Exchange XNSE
Ticker SMSPHARMA.XNSE
Market

SMS PHARMACEUTICAL ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown